Does bone health differ between patients of chronic kidney disease with and without type 2 diabetes mellitus? - A comparative cross-sectional study [0.03%]
慢性肾脏病患者与糖尿病患者的骨健康状况比较横断面研究
Varun Suryadevara,Anitha Sebastian,Rashmi K G et al.
Varun Suryadevara et al.
Evaluation of large language models for TI-RADS category extraction from free-text thyroid US reports: a comparative study with human readers [0.03%]
基于自由文本甲状腺超声报告的TI-RADS分类提取的大规模语言模型评估:与人工阅片员对比研究
Anding Dong,Lanlan Zhang,Jian Ma et al.
Anding Dong et al.
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice [0.03%]
免疫检查点抑制剂与酪氨酸激酶抑制剂联合治疗的内分泌毒性反应:从临床试验到实际应用
Sabrina Chiloiro,Maria Grazia Maratta,Simone Antonio De Sanctis et al.
Sabrina Chiloiro et al.
Combination therapies with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) have revolutionized the landscape of cancer treatment, improving the quality of life and overall survival of patients. A deep knowledge of ...
Therapeutic central lymph node dissection in papillary thyroid cancer: what is the optimal extent in unilateral nodal disease? [0.03%]
单侧中央区淋巴结转移的分化型甲状腺癌患者中央区淋巴结廓清范围的研究
Tomás Seip,Martín Gallardo,María Rita Alvo et al.
Tomás Seip et al.
Machine learning-based prediction model for Fear of progression in thyroid cancer survivors [0.03%]
基于机器学习的预测甲状腺癌幸存者进展恐惧的模型
JiaLi Shen,JiaYing Guo,YaTing Guo et al.
JiaLi Shen et al.
The effectiveness of levothyroxine starting doses after thyroidectomy is compromised by early body variations occurring after surgery [0.03%]
甲状腺切除术后左旋甲状腺素起始剂量的有效性受到手术后早期体重变化的影响
Pierpaolo Trimboli,Pietro Giacopelli,Martina Zandonà et al.
Pierpaolo Trimboli et al.
Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based Data [0.03%]
神经内分泌肿瘤研究中患者特征的评估:基于NET-PRO研究与SEER人群数据对比分析
Michael A ORorke,Bradley D McDowell,Tao Xu et al.
Michael A ORorke et al.
Purpose: We compared demographic and clinical characteristics of patients with gastroenteropancreatic (GEP) and lung neuroendocrine tumors (NETs) enrolled in the NET-PRO study to those in the U.S. Surveillance Epidemiolog...
Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer [0.03%]
hsa-miR-21-3p/sTNF-RI/IL12-p40/CCL25联合检测作为诊断乳头状甲状腺癌恶性结节的潜在标志物研究
Abdulmelik Aytatli,Abdulkadir Sahin,Neslisah Barlak et al.
Abdulmelik Aytatli et al.
Purpose: Papillary thyroid cancer (PTC) is the most common thyroid malignancy and is often difficult to distinguish from benign nodules using current diagnostic tools, resulting in unnecessary surgical interventions. This...
Alterations in gut microbiota and metabolic profiling are associated with papillary thyroid cancer and BRAFV600E mutation [0.03%]
甲状腺乳头状癌及其BRAF基因V600E突变与肠道菌群和代谢谱的改变有关
Guoan Peng,Liang Zheng,Siting Cao et al.
Guoan Peng et al.
Adverse Events Associated with Growth Hormone Therapy: A Pharmacovigilance Study [0.03%]
生长激素治疗相关的不良事件:一项药物警戒研究
Xie Zhanfang,Hu Yan,Wang Yanhong et al.
Xie Zhanfang et al.